Atrial fibrillation with or without valvular disease: is the prognosis different?

被引：0
|
作者：
Mazzone, C. [1 ]
Barbati, G. [1 ]
Carriere, C. [2 ]
Cherubini, A. [1 ]
Faganello, G. [1 ]
Cioffi, G. [3 ]
Tarantini, L. [4 ]
Poli, S. [2 ]
Sinagra, G. [2 ]
Di Lenarda, A. [1 ]
机构：
[1] ASS 1 Trieste, Cardiovasc Ctr, Trieste, Italy
[2] Univ Hosp Riuniti, Cardiovasc Dept, Trieste, Italy
[3] Villa Bianca Hosp, Trento, Italy
[4] San Martino Hosp, Belluno, Italy
来源：
EUROPEAN HEART JOURNAL | 2015年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P5297
引用
收藏
页码：907 / 907
页数：1
相关论文
共 50 条
  • [21] Metabolomic and Proteomic Analyses of Persistent Valvular Atrial Fibrillation and Non-Valvular Atrial Fibrillation
    Hu, Bo
    Ge, Wen
    Wang, Yuliang
    Zhang, Xiaobin
    Li, Tao
    Cui, Hui
    Qian, Yongjun
    Zhang, Yangyang
    Li, Zhi
    FRONTIERS IN GENETICS, 2021, 12
  • [22] Risk of Thromboembolism in Non-Valvular Atrial Fibrillation With or Without Clinical Hyperthyroidism
    Lin, Yu-Sheng
    Tsai, Hsin-Yu
    Lin, Chia-Ying
    Wu, Victor Chien-Chia
    Chen, Tien-Hsing
    Yang, Teng-Yao
    Aboyans, Victor
    Chen, Mien-Cheng
    GLOBAL HEART, 2021, 16 (01)
  • [23] Direct Oral Anticoagulants Compared With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease Without Mechanical Valves
    Dawwas, Ghadeer K.
    Lewis, James D.
    Cuker, Adam
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2025, 14 (04):
  • [24] Atrial fibrillation in pure rheumatic mitral valvular disease is expression of an atrial histological change
    Alessandri, N.
    Tufano, F.
    Petrassi, M.
    Alessandri, C.
    Di Cristofano, C.
    Della Rocca, C.
    Gallo, P.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2009, 13 (06) : 431 - 442
  • [25] Left Atrial Ganglion Ablation as an Adjunct to Atrial Fibrillation Surgery in Valvular Heart Disease
    Ware, Adam L.
    Suri, Rakesh M.
    Stulak, John M.
    Sundt, Thoralf M., III
    Schaff, Hartzell V.
    ANNALS OF THORACIC SURGERY, 2011, 91 (01): : 97 - 103
  • [26] Multiple coronary thromboemboli complicating valvular heart disease and atrial fibrillation
    Takenaka, T
    Horimoto, M
    Igarashi, K
    Yoshie, H
    Tsujino, I
    Morihira, M
    AMERICAN HEART JOURNAL, 1996, 131 (01) : 194 - 196
  • [27] Atrial valvular fibrillation: OAC or VKA?
    Vaillant, H.
    Ruelle, Y.
    Cadwallader, J.
    EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE, 2022, (188): : 480 - 480
  • [28] Thromboembolic Risk in Nonanticoagulated Patients With Atrial Fibrillation and Valvular Heart Disease
    Melgaard, Line
    Overvad, Thure Filskov
    Jensen, Martin
    Lip, Gregory Y. H.
    Larsen, Torben Bjerregaard
    Nielsen, Peter Bronnum
    JACC-CLINICAL ELECTROPHYSIOLOGY, 2020, 6 (13) : 1672 - 1682
  • [29] Atrial Fibrillation With Valvular Heart Disease - New Insight Into Clinical Outcomes -
    Kurokawa, Sayaka
    Okumura, Yasuo
    CIRCULATION JOURNAL, 2020, 84 (05) : 697 - 699
  • [30] Optimal Anticoagulation Therapy in Patients With Valvular Heart Disease or Atrial Fibrillation
    McLeod, Christopher J.
    Gersh, Bernard J.
    ARCHIVES OF INTERNAL MEDICINE, 2009, 169 (21) : 2032 - 2033
12345